Arrhythmias in Patients With COVID-19
ACOVID
The ACOVID-19 Study - A Prospective Cohort Study Investigating the Acute Effect of COVID-19 on the Heart by Continuous ECG Monitoring
1 other identifier
observational
1,000
1 country
1
Brief Summary
The study is a prospective clinical cohort study of consecutive patients hospitalized at all hospitals of greater Copenhagen with a laboratory confirmed diagnosis of COVID-19. The investigators aim to examine if continuous ECG monitoring can be used to understand the contribution of COVID-19 infection in the acute phase to the development of cardiac arrhythmias, especially focusing on cardiovascular outcomes. In all patients included, the investigators aim to examine if continuous ECG monitoring - alone and in combination with biomarkers - can be used to detect early signs of cardiac complications and predict long-term risk of cardiovascular morbidity and mortality following COVID-19 infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2020
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 16, 2020
CompletedFirst Submitted
Initial submission to the registry
May 19, 2020
CompletedFirst Posted
Study publicly available on registry
May 20, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2020
CompletedSeptember 9, 2020
September 1, 2020
5 months
May 19, 2020
September 6, 2020
Conditions
Outcome Measures
Primary Outcomes (2)
In-hospital mortality during hospitalization and a confirmed COVID-19 diagnosis
4 months
Incident intensive care unit admission during hospitalization and a confirmed COVID-19 diagnosis
4 months
Secondary Outcomes (3)
Incident pulmonary embolism during hospitalization and a confirmed COVID-19 diagnosis
4 months
Incident cardiac arrest during hospitalization and a confirmed COVID-19 diagnosis
4 months
Incident hypoxic respiratory failure during hospitalization and a confirmed COVID-19 diagnosis
4 months
Interventions
ECG monitoring
Eligibility Criteria
In.patients from hospitals of the greater Copenhagen area
You may qualify if:
- All patients hospitalized at hospitals of greater Copenhagen area and Zealand with a laboratory confirmed diagnosis of COVID-19 \> 18 years of age.
You may not qualify if:
- Persons not able to cooperate
- Persons unable to understand and sign "informed consent"
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Cardiology, Herlev & Gentofte Hospital
Copenhagen, Hellerup, 2900, Denmark
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor and Research Director
Study Record Dates
First Submitted
May 19, 2020
First Posted
May 20, 2020
Study Start
April 16, 2020
Primary Completion
September 1, 2020
Study Completion
September 1, 2020
Last Updated
September 9, 2020
Record last verified: 2020-09